REGENERON PHARMACEUTICALS, INC. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
REGENERON PHARMACEUTICALS, INC. (REGN) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $12.74 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2011-02-17
- REGENERON PHARMACEUTICALS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2010 was $12.74M, a 404.44% increase from fiscal 2009.
- REGENERON PHARMACEUTICALS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2009 was $2.52M, a 72.99% decline from fiscal 2008.
- REGENERON PHARMACEUTICALS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2008 was $9.35M.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|
| 2010-12-31 | $12.74M 10-K · filed 2011-02-17 |
| 2009-12-31 | $2.52M 10-K · filed 2011-02-17 |
| 2008-12-31 | $9.35M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |